Source: Heart, Lung and Circulation. Unidade: FCF
Subjects: INSUFICIÊNCIA CARDÍACA, MIOSINA
ABNT
BARBOSA, Amanda Veiga et al. Does sex affect the efficacy, safety, and quality of life outcomes for patients using angiotensin receptor neprilysin inhibitor, soluble guanylate cyclase stimulators, and cardiac myosin activators in heart failure? a systematic review. Heart, Lung and Circulation, v. 34, n. 11, p. 1169-1178, 2025Tradução . . Disponível em: https://dx.doi.org/10.1016/j.hlc.2025.04.082. Acesso em: 14 fev. 2026.APA
Barbosa, A. V., Silva, L. C. A., Rotta, I., & Aguiar, P. M. (2025). Does sex affect the efficacy, safety, and quality of life outcomes for patients using angiotensin receptor neprilysin inhibitor, soluble guanylate cyclase stimulators, and cardiac myosin activators in heart failure? a systematic review. Heart, Lung and Circulation, 34( 11), 1169-1178. doi:10.1016/j.hlc.2025.04.082NLM
Barbosa AV, Silva LCA, Rotta I, Aguiar PM. Does sex affect the efficacy, safety, and quality of life outcomes for patients using angiotensin receptor neprilysin inhibitor, soluble guanylate cyclase stimulators, and cardiac myosin activators in heart failure? a systematic review [Internet]. Heart, Lung and Circulation. 2025 ; 34( 11): 1169-1178.[citado 2026 fev. 14 ] Available from: https://dx.doi.org/10.1016/j.hlc.2025.04.082Vancouver
Barbosa AV, Silva LCA, Rotta I, Aguiar PM. Does sex affect the efficacy, safety, and quality of life outcomes for patients using angiotensin receptor neprilysin inhibitor, soluble guanylate cyclase stimulators, and cardiac myosin activators in heart failure? a systematic review [Internet]. Heart, Lung and Circulation. 2025 ; 34( 11): 1169-1178.[citado 2026 fev. 14 ] Available from: https://dx.doi.org/10.1016/j.hlc.2025.04.082
